Patents by Inventor Bo Jung KIM

Bo Jung KIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12124733
    Abstract: A memory system according to the present technology may include a plurality of memory devices including a plurality of blocks configured of memory cells and a memory controller configured to control the plurality of memory devices corresponding to a plurality of zones by configuring the plurality of zones with the plurality of blocks included in each of the plurality of memory devices, wherein the memory controller is further configured to: receive a write request from a host, determine a target zone indicated by the write request among the plurality of zones, and determine a logical address of the target zone on which a write operation is to be started based on a write pointer and an offset corresponding to the target zone.
    Type: Grant
    Filed: June 1, 2023
    Date of Patent: October 22, 2024
    Assignee: SK hynix Inc.
    Inventors: Yu Jung Lee, Bo Kyeong Kim, Do Hyeong Lee, Min Kyu Choi
  • Patent number: 11544771
    Abstract: The present invention relates to an e-commerce method capable of integrated ordering and integrated shipment to help a user residing abroad to use a domestic online shopping mall, the e-commerce method including displaying a plurality of online shopping malls on a user terminal, displaying an integrated order product list for a plurality of products selected by a user's input from at least one online shopping mall on the user terminal, receiving a purchase-on-behalf request event for a product of the integrated order product list from the user terminal, receiving first-shipment completion information from an administrator when the first shipment of the product purchased on behalf of the user to a predetermined shipment destination is completed, and displaying an integrated shipping method list including a plurality of shipping methods corresponding to the product for the second shipment of the product to a user shipment destination on the user terminal.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: January 3, 2023
    Assignee: BRINGKO CO., LTD.
    Inventor: Bo Jung Kim
  • Publication number: 20220044306
    Abstract: The present invention relates to an e-commerce method capable of integrated ordering and integrated shipment to help a user residing abroad to use a domestic online shopping mall, the e-commerce method including displaying a plurality of online shopping malls on a user terminal, displaying an integrated order product list for a plurality of products selected by a user's input from at least one online shopping mall on the user terminal, receiving a purchase-on-behalf request event for a product of the integrated order product list from the user terminal, receiving first-shipment completion information from an administrator when the first shipment of the product purchased on behalf of the user to a predetermined shipment destination is completed, and displaying an integrated shipping method list including a plurality of shipping methods corresponding to the product for the second shipment of the product to a user shipment destination on the user terminal.
    Type: Application
    Filed: July 31, 2020
    Publication date: February 10, 2022
    Inventor: Bo Jung KIM
  • Patent number: 10927085
    Abstract: Disclosed are a compound represented by Formula (1) below, or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R3,and Xi to X6 are the same as defined in claim 1.
    Type: Grant
    Filed: December 30, 2014
    Date of Patent: February 23, 2021
    Assignee: HUEN Co., Ltd.
    Inventors: Whee Seong Lee, Mi Jung Lee, Bo Jung Kim, Tae Cheul Roh, Seung Hoon Lee, Kyu Dae Lee, You-Hui Lee, Tae Hwan Kwak
  • Patent number: 10766882
    Abstract: Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R6, X1 to X4, and n are the same as defined in claim 1.
    Type: Grant
    Filed: April 23, 2018
    Date of Patent: September 8, 2020
    Assignee: YUNGJIN PHARM CO., LTD.
    Inventors: Whee Seong Lee, Mi Jung Lee, Bo Jung Kim, Tae Cheul Roh, Seung Hoon Lee, Kyu Dae Lee, You-Hui Lee, Tae Hwan Kwak
  • Publication number: 20180258079
    Abstract: Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R6, X1 to X4, and n are the same as defined in claim 1.
    Type: Application
    Filed: April 23, 2018
    Publication date: September 13, 2018
    Inventors: Whee Seong Lee, Mi Jung Lee, Bo Jung Kim, Tae Cheul Roh, Seung Hoon Lee, Kyu Dae Lee, You-Hui Lee, Tae Hwan Kwak
  • Patent number: 9975883
    Abstract: Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R6, X1 to X4, and n are the same as defined in Claim 1.
    Type: Grant
    Filed: December 30, 2014
    Date of Patent: May 22, 2018
    Assignee: YUNGJIN PHARM. CO., LTD.
    Inventors: Whee Seong Lee, Mi Jung Lee, Bo Jung Kim, Tae Cheul Roh, Seung Hoon Lee, Kyu Dae Lee, You-Hui Lee, Tae Hwan Kwak
  • Publication number: 20160376258
    Abstract: Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R6, X1 to X4, and n are the same as defined in Claim 1.
    Type: Application
    Filed: December 30, 2014
    Publication date: December 29, 2016
    Applicant: KT&G LIFE SCIENCES CORPORATION
    Inventors: Whee Seong LEE, Mi Jung LEE, Bo Jung KIM, Tae Cheul ROH, Seung Hoon LEE, Kyu Dae LEE, You-Hui LEE, Tae Hwan KWAK
  • Publication number: 20160376243
    Abstract: Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R3, and X1 to X6 are the same as defined in Claim 1.
    Type: Application
    Filed: December 30, 2014
    Publication date: December 29, 2016
    Applicant: KT&G LIFE SCIENCES CORPORATION
    Inventors: Whee Seong LEE, Mi Jung LEE, Bo Jung KIM, Tae Cheul ROH, Seung Hoon LEE, Kyu Dae LEE, You-Hui LEE, Tae Hwan KWAK